PREDATOR: Neoadjuvant Gene Prediction for Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02067416
Recruitment Status : Terminated (Funding agent withdrew funding)
First Posted : February 20, 2014
Last Update Posted : September 14, 2016
GE Healthcare
The Methodist Hospital System
Information provided by (Responsible Party):
Angel Augusto Rodriguez, MD, The Methodist Hospital System

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Primary Completion Date : June 2014
  Study Completion Date : June 2014